Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Steatocystoma multiplex.

David H Chu1

  • 1Ronald O. Perelman Department of Dermatology, New York University, USA.

Dermatology Online Journal
|November 5, 2003
PubMed
Summary
This summary is machine-generated.

A rare case of steatocystoma multiplex, a skin cyst disorder, is presented in a young man. This condition typically affects the trunk and limbs, with recent reports noting acral predominance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks.

American journal of clinical dermatology·2025
Same author

Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials.

Dermatology and therapy·2025
Same author

Early Evidence of Safety, Clinical Benefit, and Pharmacokinetics of Roflumilast Cream 0.3% Once Daily for Treatment of Mild or Moderate Plaque Psoriasis in Children Aged 2-11 Years.

Pediatric dermatology·2025
Same author

Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial.

JAMA dermatology·2025
Same author

Patient and healthcare provider perspectives on treatment patterns and patient satisfaction of seborrheic dermatitis in the United States.

The Journal of dermatological treatment·2025
Same author

Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled Trial.

Pediatric dermatology·2025
Same journal

Pellagra associated with iron deficiency.

Dermatology online journal·2026
Same journal

Demodicosis: A frequently underrecognized cause of recalcitrant ear pruritus.

Dermatology online journal·2026
Same journal

Association of alopecia areata with COVID-19 vaccination: A vaccine adverse events reporting system analysis.

Dermatology online journal·2026
Same journal

Gender based price differences in 5% minoxidil foam: The impact of generic alternatives and bulk packaging.

Dermatology online journal·2026
Same journal

Retrospective analysis of filler complications reported in the manufacturer and user facility device experience database from 2015 to 2025.

Dermatology online journal·2026
Same journal

Characterizing barriers to care in patients with hidradenitis suppurativa.

Dermatology online journal·2026
See all related articles

Area of Science:

  • Dermatology
  • Genetics
  • Pathology

Background:

  • Steatocystoma multiplex is a benign, inherited skin condition characterized by multiple subcutaneous cysts.
  • Cysts typically manifest on the trunk and proximal extremities, presenting as asymptomatic nodules.
  • Recent literature highlights variations in presentation, including acral predominance.

Observation:

  • A 25-year-old male patient presented with a 20-year history of asymptomatic nodules.
  • Histopathological analysis confirmed the nodules as steatocystoma multiplex.
  • The patient's presentation included lesions on the arms and trunk.

Findings:

  • The case aligns with the general characteristics of steatocystoma multiplex.
  • The distribution of lesions in this patient is consistent with typical presentations.

Related Experiment Videos

  • The underlying etiology is hypothesized to involve alterations in keratin 17 structure.

    • Implications:

    • This case contributes to the understanding of steatocystoma multiplex variations.
    • Further research into keratin 17's role may elucidate disease mechanisms.
    • Current treatment options include surgical excision, oral retinoids, and cryotherapy.